Various neuropeptides related to the energy equilibrium affect bone growth in show that NPW promotes the proliferation and early differentiation of murine chondrocyte via GPR7 activation, as well as PKA and PKC-dependent signalling cascades, which may be involved in endochondral bone formation.
| INTRODUCTION
Neuropeptides W (NPW) and Neuropeptides B (NPB) have been identified as endogenetic ligands of G-protein receptors (GPR) 7 and 8.
1,2 Both GPR7 and GPR8 are expressed in humans, but GPR8 is absent in rodents. 3 Neuropeptides W, NPB and their receptors are mainly expressed in the central and periphery issues, which are involved in many physiological processes, including inflammatory pain, energy homeostasis, cardiovascular functions, immune system, stress and the neuroendocrine and respiratory systems. [4] [5] [6] Previous studies have detected NPW/NPB mRNA, including bone marrow, femur and costal cartilagein, in humans, rats, pigs and chickens. 1, 7, 8 The effect of G protein activation was mediated by protein kinase A (PKA), protein kinase C (PKC) and the mitogen-activated protein kinases (MAPKs) cascades reaction. 9, 10 The down-regulation or inhibition of PKA and PKC blocks chondrogenesis. 11, 12 The proliferation and differentiation of chondrocytes are regulated by PKC-mediated p38 MAPK and the ERK1/2 signalling pathway. 13 The PKA and PKC cascades are relevant to the secret agogue effect of NPW and NPB in human adrenocortical cells. 9 Neuropeptides W stimulates the proliferation of NCI-H295 cells, which are derived from human adrenocortical carcinoma by exerting the ERK1/2 pathway, 14 which is considered a crucial growth factor in rat adrenocortical cells. 15 Neuropeptides and their receptors are expressed in bone tissue and are involved in bone development in humans and animals. [16] [17] [18] Neuropeptides W, NPB and their receptors are expressed and inhibited proliferative activity in cultured rat calvarial osteoblast-like (ROB) cells. 19 However, little is known about whether NPW/B can regulate endochondral bone formation. The role of NPW/B in the regulation of the chondrocyte function has not been characterized so far. Therefore, we used immunohistochemical analyses to assess the expression of NPW and it's receptor in the growth plates of mice. We also identify the role of NPW and GPR7 in chondrocyte using an excellent in vitro model cell line called ATDC5 for chondrocyte proliferation and differentiation. The ATDC5 cell line is derived from AT805 teratocarcinoma cells and is characterized as a chondrogenic cell line that is capable of differentiating into chondrocytes. 20, 21 The molecular analysis of early-and late-phase differentiation markers of chondrocytes in vivo can also be mimicked by ATDC5 cells in vitro. 
| MATERIALS AND METHODS

| Animals and reagents
| Immunohistochemistry analysis
Slides were processed as described above for the immunohistochemical analysis. 22 The tibiofemoral joints were fixed briefly in 10%
paraformaldehyde for 24 hours after the knee samples were harvested. The fixed femoral condyles were decalcified in 10% EDTA for 7 days at 37°C. After graded ethanol dehydration and dimethylbenzene vitrification, the femoral condyles were embedded in paraffin and sectioned at 5 μm thickness. The sections were then incubated with primary antibodies against anti-NPW and anti-GPR7
antibodies overnight at 4°C. The biotinylated secondary antibody and streptavidin peroxidase solution were then used to visualize the sections.
| Cell culture
ATDC5 cells were cultured in 1:1 mixed DMEM and Ham'sF-12 media containing 10% fetal bovine serum, 100 units/mL penicillin and 100 μg/mL streptomycin (Sigma-Aldrich, St. Louis, MO). The ATDC5 cells were cultured at 37°C in a humidified atmosphere of 5% CO 2 in air. Insulin, transferin and selenite (ITS, Sigma-Aldrich) were added to the medium to induce ATDC5 cell differentiation in the culture.
| Small interfering RNA transfections
The ATDC5 cells were transfected with small interfering RNA (siRNA) of GPR7 or negative control siRNA using a Lipofectamine 2000 reagent according to the manufacturer's protocols. The siRNA of GPR7 used in the experiment was designed and synthesized by GenPharma Co., Ltd. (Shanghai, China), and the sequences were as follows: sense 5ʹ-CGCAUGAAGACUGUUACCATT-3ʹ, antisense:
5ʹ-UGGUAACAGUCUUCAUGCGTT-3ʹ. RT-PCR was used to verify the GPR7 knockout efficiency.
| RT-PCR analysis
The total RNA was extracted using TRNzol Universal Reagent (Tiangen Biotech, Beijing, China) according to the manufacturer's instructions. The first strand of cDNA was produced using the First-Strand cDNA Synthesis Kit (Thermo Scientific, USA). The reaction conditions for the PCR and gene-specific primers ( 
| Western blotting analysis
The Western blotting analysis was described previously. 24 Briefly, repeated at least three times using triplicate cultures (n = 9).
| BrdU cell proliferation assay
Cell proliferation was assessed using BrdU cell proliferation assay kits according to the manufacturer's instructions. Briefly, the cells sus- After washing, cells were incubated with a pre-diluted detector antibody for 1 hour at room temperature. Acid stop solution was added after incubation with HRP-conjugated secondary antibody for 1 hour at room temperature. The optical density (OD) was then measured at 450 nm using an automated microplate reader.
| Alcian blue and Alizarin red staining
The cells were cultured in 12-well plates at a density of 50 000 cell/ well for 4, 7, 14 and 21 days, and were treated with or without indi- 
| Alkaline phosphatase assay
ATDC5 cells were seeded in 6-well plates at a density of 100 000 cell/well and then treated with the indicated amounts of T A B L E 1 Primers used for PCR (all primers suitable for mouse cDNA, S, sense; A, antisense)
Gene Sequence
Accession number
GPR, G-protein receptor; NPW, neuropeptides W. 
| Statistical analysis
All the results were reported as means ± SEM for 3-5 times. ANOVA was used to analyse the differences between the groups, followed by the TukeyeKramer or Dunnett's multi-comparison test with PASW Software (SPSS Inc., Chicago, IL, USA). P < 0.05 was considered statistically significant.
| RESULTS
| Detection of NPWand GPR7 expression in the growth plate
An immunohistochemical study of the tibiofemoral joints, which used specific antibodies, detected NPW and GPR7 proteins in the round chondrocytes in the growth plate. As shown in 
| Expression levels of NPW and GPR7 when differentiating ATDC5 cells
We used a differential medium (containing 1% insulin, transferrin Figure 2D ).
| Effect of NPW-23 on ATDC5 proliferation
As NPW and NPB were thought to act as regulators of cell prolifera- 
| Effect of NPW-23 on markers of chondrogenic differentiation
To investigate the effects of NPW-23 on the chondrogenic differentiation, ATDC5 cells were cultured in differentiation medium 
| The effect of NPW-23 on major regulatory signalling pathways in chondrocytes
We used RT-PCR to study the major regulators of chondrogenesis that mediate the effects of NPW-23ʹ on ATDC5 cells. As shown in Figure 5A , the NPW-23 increased early differentiation when evaluated by Coll II mRNA expression, which was sensitive to the specific inhibitors of the PKA, PKC and p38 MAPK pathways, while the ERK1/2 and JNK inhibitors had no effect. The aggrecan gene expression, which acts as a marker of early chondrocyte differentiation,
showed similar results ( Figure 5B ). Furthermore, p21 expression, which is essential for the chondrogenesis of ATDC5 cells, was inhibited by the specific inhibitors of PKA, PKC, ERK1/2 and p38 MAPK, but showed no reaction to the JNK inhibitor( Figure 5C 
| DISCUSSION
The G protein-coupled receptor (GPR) plays a key role in regulating bone physiology and pathology. As one subtype of the GPR family, GPR7 is expressed in many brain and periphery tissues. 25 Neuropeptides W is a natural agonist of GPR7 and has universal distribution in the brain tissue. 3, 7 It is also expressed in periphery tissues and is involved in different cellular processes via GPR7, including hormonal and energy homeostasis. [26] [27] [28] [29] Our results showed the first time that ITS treatment in ATDC5 cells is an effective model for studying chondrocyte differentiation. 30 Our results show that NPW-23 expression increased on day 4, peaked on day 7 and decreased on day 14. In contrast, the GPR7 mRNA decreased in a time-dependent manner during the differentiation of the ATDC5 cells, which was induced by ITS. These results show that NPW-active GPR7 may regulate the early differentiation of ATDC5.
The expression of mRNA in downstream signalling pathways was tested to study the mechanism of NPW that is involved in chondrogenesis. The p21 is a well-known G1 cell cycle regulator that is related through chondrocyte proliferation and differentiation. Furthermore, the increase of endogenous p21 stimulated early chondrogenic differentiation in the ATDC5 cells. 22 Sox9, a chondrogenic transcription factor, is necessary for chondrogenesis. 31 In this study, the expression of Sox-9 increased on day 14 during the We also found that NPW induced Moreover, NPW-23 stimulated the phosphrylation of PKA, PKC and p38 in a time-and concentration-dependent manner. These data imply that the promotion of proliferation and differentiation of ATDC5 cells induced by NPW is mediated by the PKA and PKC signalling pathways. It may be true that PKC mediates the p38 MAPK signal pathway in ATDC5 cells. 13 However, further investigation is required to determine the contribution of PKA/PKC signalling in mediating GPR7 activation in murine chondrocyte.
In conclusion, this study is the first to suggest that NPW binds GPR7 in order to promote proliferation and early differentiation of murine chondrocyte. This effect was because of the activation of the adenylate cyclase/PKA and the phospholipase C/PKC cascades, as well as its promoted p38 MAPK phosphorylation. Earlier studies also suggest that NPW/NPB exists in the blood and systemic veins of rats, 41 which indicates that NPW/GPR7 also affects cartilage F I G U R E 5 Neuropeptide W-23 (NPW-23)-enhanced differentiation of ATDC5 cells through the protein kinase A, protein kinase C, ERK1/2, and p38 signalling pathways. Cells were cultured in differentiation medium (1% ITS) and incubated with or without NPW-23 (200 ng/mL). On day 7 of the culture process, the cells were in the presence or absence of specific inhibitors of the different signalling pathways (CYM50769; PD98059; SB203580; Chele; H-89). After 12 h, the total RNA was extracted and (A) Coll II, (B) aggrecan, and (C) p21 mRNA were detected by quantitative RT-PCR. Each experiment was repeated at least three times. The data represent triplicate samples in two independent experiments. *P < 0.05 vs control group, # P < 0.05 vs NPW-23 group.
functions in vivo. However, we failed to identify the possible mechanism of NPW action on chondrocyte in vivo. We hope to study this in the future.
